X0206 3 2021-11-01 0 0001314102 EyePoint Pharmaceuticals, Inc. EYPT 0001630864 Duker Jay S. C/O EYEPOINT PHARMACEUTICALS, INC. 480 PLEASANT STREET WATERTOWN MA 02472 false true false false Chief Operating Officer Common Stock 5657.00 D Employee Stock Option (right to buy) 31.70 2026-09-26 Common Stock 4000.00 D Employee Stock Option (right to buy) 26.50 2029-02-21 Common Stock 4000.00 D Employee Stock Option (right to buy) 19.50 2028-06-21 Common Stock 2666.00 D Employee Stock Option (right to buy) 13.13 2031-02-09 Common Stock 60300.00 D Employee Stock Option (right to buy) 12.90 2030-02-28 Common Stock 3350.00 D Employee Stock Option (right to buy) 7.20 2030-07-13 Common Stock 25000.00 D Restricted Stock Units Common Stock 14900.00 D This option became fully exercisable on 12/12/2019 This option became fully exercisable on 2/21/2020 This option became fully exercisable on 6/21/2019. The option to purchase will vest and become exercisable over a four year period as follows: 25% on 2/9/2022 and then ratably over the remaining thirty-six months This option became fully exercisable on 2/28/2021 The option to purchase will vest and become exercisable as follows: 25% at 7/13/2021 and the remainder ratably, on a monthly basis, over the remaining three years. The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. /s/ Ron Honig, Attorney-in-Fact 2021-11-03